Search Results - "SLOAND, Elaine M"
-
1
Factors Affecting Response and Survival in Patients With Myelodysplasia Treated With Immunosuppressive Therapy
Published in Journal of clinical oncology (20-05-2008)“…Marrow failure in some patients with myelodysplastic syndrome (MDS) responds to immunosuppressive treatment (IST), but long-term outcome after IST has not been…”
Get full text
Journal Article -
2
Alemtuzumab Treatment of Intermediate-1 Myelodysplasia Patients Is Associated With Sustained Improvement in Blood Counts and Cytogenetic Remissions
Published in Journal of clinical oncology (10-12-2010)“…Myelodysplastic syndromes (MDS) are characterized by ineffective hematopoiesis and progression to leukemia. Clinical and experimental evidence suggests an…”
Get full text
Journal Article -
3
Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study
Published in Haematologica (Roma) (01-03-2009)“…1 Hematology Branch and 2 Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA…”
Get full text
Journal Article -
4
The Role of the Immune System in Myelodysplasia: Implications for Therapy
Published in Seminars in hematology (2008)“…Patients with myelodysplastic syndrome (MDS) have intrinsic, usually acquired genetic defects in their hematopoietic stem cells, but some others exhibit…”
Get full text
Journal Article -
5
Hematopoietic-specific microRNA expression in human cells
Published in Leukemia research (01-05-2006)“…We examined expression profiles of hematopoietic tissue-specific microRNAs (miRNAs; miR-142, miR-155, miR-181 and miR-223) in 17 commercially available…”
Get full text
Journal Article -
6
Granulocyte Colony-Stimulating Factor Preferentially Stimulates Proliferation of Monosomy 7 Cells Bearing the Isoform IV Receptor
Published in Proceedings of the National Academy of Sciences - PNAS (26-09-2006)“…Granulocyte colony-stimulating factor (GCSF) administration has been linked to the development of monosomy 7 in severe congenital neutropenia and aplastic…”
Get full text
Journal Article -
7
Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia
Published in Blood (01-05-2002)“…A serious complication of aplastic anemia (AA) is its evolution to clonal hematologic diseases such as myelodysplasia (MDS) and leukemia, which is usually…”
Get full text
Journal Article -
8
Hypocellular Myelodysplasia
Published in Hematology/oncology clinics of North America (01-04-2009)“…Myelodysplasia must be considered in the differential diagnosis of patients who have bone marrow failure, but bone marrow cellularity per se may not…”
Get full text
Journal Article -
9
Immunosuppression for Myelodysplastic Syndrome: How Bench to Bedside to Bench Research Led to Success
Published in Hematology/oncology clinics of North America (01-04-2010)“…Laboratory evidence and clinical evidence suggest that some patients with myelodysplastic syndrome (MDS) have immunologically mediated disease. This article…”
Get full text
Journal Article -
10
Long-term follow-up of patients with moderate aplastic anemia and pure red cell aplasia treated with daclizumab
Published in Haematologica (Roma) (01-03-2010)“…Pure red cell aplasia and moderate aplastic anemia are marrow failure states with an immune pathogenesis. Previously, we described short-term improvements in…”
Get full text
Journal Article -
11
Association of Telomere Length of Peripheral Blood Leukocytes With Hematopoietic Relapse, Malignant Transformation, and Survival in Severe Aplastic Anemia
Published in JAMA : the journal of the American Medical Association (22-09-2010)“…CONTEXT Critically short telomeres produce apoptosis, cell senescence, and chromosomal instability in tissue culture and animal models. Variations in telomere…”
Get full text
Journal Article -
12
Myelodysplastic Syndromes: Introduction
Published in Seminars in hematology (2008)Get full text
Journal Article -
13
Targeting Immune Dysregulation in Myelodysplastic Syndromes
Published in JAMA (23-02-2011)“…Myelodysplastic syndromes (MDS) are a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis and a tendency to develop…”
Get full text
Journal Article Conference Proceeding -
14
CD34 cells from patients with trisomy 8 myelodysplastic syndrome (MDS) express early apoptotic markers but avoid programmed cell death by up-regulation of antiapoptotic proteins
Published in Blood (15-03-2007)“…CD34 cells from patients with trisomy 8 myelodysplastic syndrome (MDS) are distinguished from other MDS cells and from normal hematopoietic cells by their…”
Get full text
Journal Article -
15
T-cell immune responses to Wilms tumor 1 protein in myelodysplasia responsive to immunosuppressive therapy
Published in Blood (03-03-2011)“…Clinical observations and laboratory evidence link bone marrow failure in myelodysplastic syndrome (MDS) to a T cell–mediated immune process that is responsive…”
Get full text
Journal Article -
16
Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia
Published in Blood (15-04-2007)“…The natural history of EBV and CMV reactivation and the potential for serious complications following antibody-based immunosuppressive treatment for bone…”
Get full text
Journal Article -
17
Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome
Published in Blood (01-08-2005)“…Clinical observations and experimental evidence link bone marrow failure in myelodysplastic syndrome (MD33) with a T cell–dominated autoimmune process…”
Get full text
Journal Article -
18
Directed therapy for patients with myelodysplastic syndromes (MDS) by suppression of cyclin D1 with ON 01910.Na
Published in Leukemia research (01-08-2012)“…Abstract Background We previously demonstrated upregulation of c-myc, survivin, and cyclin D1 in CD34+ bone marrow mononuclear cells (BMMNCs) of patients with…”
Get full text
Journal Article -
19
Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities
Published in Blood (15-12-2004)“…Aneuploidy, especially monosomy 7 and trisomy 8, is a frequent cytogenetic abnormality in the myelodysplastic syndromes (MDSs). Patients with monosomy 7 and…”
Get full text
Journal Article -
20
Primitive quiescent CD34+ cells in chronic myeloid leukemia are targeted by in vitro expanded natural killer cells, which are functionally enhanced by bortezomib
Published in Blood (22-01-2009)“…Primitive quiescent CD34+ chronic myeloid leukemia (CML) cells are more biologically resistant to tyrosine kinase inhibitors than their cycling counterparts;…”
Get full text
Journal Article